(R)-佐匹克隆结构式
|
常用名 | (R)-佐匹克隆 | 英文名 | [(7R)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate |
|---|---|---|---|---|
| CAS号 | 138680-08-7 | 分子量 | 388.80800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C17H17ClN6O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (R)-佐匹克隆杂质 |
|---|---|
| 英文名 | [(7R)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate |
| 中文别名 | (R)-佐匹克隆 |
| 英文别名 | 更多 |
| 分子式 | C17H17ClN6O3 |
|---|---|
| 分子量 | 388.80800 |
| 精确质量 | 388.10500 |
| PSA | 91.76000 |
| LogP | 1.50880 |
| InChIKey | GBBSUAFBMRNDJC-MRXNPFEDSA-N |
| SMILES | CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1 |
| 危险品运输编码 | NONH for all modes of transport |
|---|
|
~99%
(R)-佐匹克隆 138680-08-7 |
| 文献:ESTEVE QUIMICA, S.A. Patent: EP2020403 A1, 2009 ; Location in patent: Page/Page column 8 ; |
|
~83%
(R)-佐匹克隆 138680-08-7 |
| 文献:LEK Pharmaceuticals d.d. Patent: EP2345655 A1, 2011 ; Location in patent: Page/Page column 12 ; |
|
~46%
(R)-佐匹克隆 138680-08-7 |
| 文献:USV LIMITED Patent: WO2009/63486 A2, 2009 ; Location in patent: Page/Page column 22 ; |
|
~42%
(R)-佐匹克隆 138680-08-7 |
| 文献:LEK Pharmaceuticals d.d. Patent: EP2345655 A1, 2011 ; Location in patent: Page/Page column 14 ; |
|
~%
(R)-佐匹克隆 138680-08-7 |
| 文献:Wessel, Thomas; Caron, Judy Patent: US2005/222156 A1, 2005 ; Location in patent: Page/Page column 3 ; |
|
~24%
(R)-佐匹克隆 138680-08-7 |
| 文献:LEK Pharmaceuticals d.d. Patent: EP2345655 A1, 2011 ; Location in patent: Page/Page column 12 ; |
| ZPC |
| R-(-)-zopiclone |
| Tocris-1094 |
| Lopac-Z-4900 |
| (R)-zolpiclone |
| (5R)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate |
| Zopiclone,(R) |
| (+)-6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3-4-b]pyrazine |
| (-)-Zopiclone |
| (R)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo-[3,4-b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate |